FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| QuVa Pharma | 079937015 | Morphine Sulfate | 1 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 50 mg/50 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 50 mg/50 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 2 mg/2 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 30 mg/30 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 1 mg/2 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 50 mg/50 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 100 mg/100 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Neostigmine Methylsulfate | 5 mg/5 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Atropine Sulfate | .8 mg/2 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Atropine Sulfate | 1 mg/2.5 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Norepinephrine | 4 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Norepinephrine | 4 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Norepinephrine | 8 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Norepinephrine | 8 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Oxytocin | 30 [USP'U]/500 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Phenylephrine Hydrochloride | 400 ug/10 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Rocuronium Bromide | 100 mg/10 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Rocuronium Bromide | 100 mg/10 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride | 500 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride | 200 mg/100 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride | 800 mg/400 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride | 400 mg/200 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride | 1 g/500 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/200 mL; 400 ug/200 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/200 mL; 400 ug/200 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride; Fentanyl Citrate | 500 mg/250 mL; 500 ug/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Ropivacaine Hydrochloride; Fentanyl Citrate | 400 mg/200 mL; 400 ug/200 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Succinylcholine Chloride | 100 mg/5 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Succinylcholine Chloride | 200 mg/10 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Succinylcholine Chloride | 140 mg/7 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Bupivacaine Hydrochloride; Fentanyl Citrate | 125 mg/100 mL; 200 ug/100 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Bupivacaine Hydrochloride; Fentanyl Citrate | 125 mg/100 mL; 200 ug/100 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Bupivacaine Hydrochloride; Fentanyl Citrate | 250 mg/250 mL; 500 ug/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Bupivacaine Hydrochloride; Fentanyl Citrate | 100 mg/100 mL; 200 ug/100 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Bupivacaine Hydrochloride; Fentanyl Citrate | 156.25 mg/250 mL; 500 ug/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Bupivacaine Hydrochloride; Fentanyl Citrate | 156.25 mg/250 mL; 500 ug/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Bupivacaine Hydrochloride; Fentanyl Citrate | 250 mg/250 mL; 500 ug/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Bupivacaine Hydrochloride; Fentanyl Citrate | 100 mg/100 mL; 200 ug/100 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Vancomycin Hydrochloride | 1250 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Bupivacaine Hydrochloride; Fentanyl Citrate | 333.4 mg/200 mL; 800 ug/200 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Bupivacaine Hydrochloride; Fentanyl Citrate | 312.5 mg/250 mL; 500 ug/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Cefazolin Sodium | 2 g/100 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Cefazolin Sodium | 2 g/100 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Cefazolin Sodium | 1 g/10 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Cefazolin Sodium | 2 g/20 mL | 2020-2 | source_no_ndc | 2026-11-12 | |||
| QuVa Pharma | 079937015 | Clonidine Hydrochloride; Ropivacaine Hydrochloride; Racepinephrine Hydrochloride; Ketorolac Tromethamine | .04 mg/50 mL; 123 mg/50 mL; .25 mg/50 mL; 15 mg/50 mL | 2020-2 | source_no_ndc | 2026-11-12 |